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In individual animals affected by transmissible spongiform encephalopathies, different disease phenotypes can be
identified which are attributed to different strains of the agent. In the absence of reliable technology to fully
characterise the agent, classification of disease phenotype has been used as a strain typing tool which can be
applied in any host. This approach uses standardised data on biological parameters, established for a single host, to
allow comparison of different prion sources. Traditionally prion strain characterisation in wild type mice is based on
incubation periods and lesion profiles after the stabilisation of the agent into the new host which requires serial
passages. Such analysis can take many years, due to prolonged incubation periods. The current study demonstrates
that the PrPSc patterns produced by one serial passage in wild type mice of bovine or ovine BSE were consistent,
stable and showed minimal and predictable differences from mouse-stabilised reference strains. This biological
property makes PrPSc deposition pattern mapping a powerful tool in the identification and definition of TSE strains
on primary isolation, making the process of characterisation faster and cheaper than a serial passage protocol. It can
be applied to individual mice and therefore it is better suited to identify strain diversity within single inocula in case
of co-infections or identify strains in cases where insufficient mice succumb to disease for robust lesion profiles to
be constructed. The detailed description presented in this study provides a reference document for identifying BSE
in wild type mice.Introduction
Transmissible spongiform encephalopathies (TSEs) are
fatal neurodegenerative diseases that affect humans and
animals. The hallmark lesion of TSEs is spongiform
changes in the brains of affected subjects. According to
the prion hypothesis TSEs are caused by proteinaceous
infectious particles consisting of abnormal isoforms
(PrPSc) of the normal cellular prion protein (PrPC) [1-3]
although this view is not accepted universally [4-6]. Des-
pite the disagreement in the scientific community
regarding the exact nature of the infectious agent, PrPSc
is considered to be a ubiquitous marker of TSE disease
and it accumulates in the brains of affected subjects
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distribution, and reproduction in any mediumspongiform changes become evident [7,8]. Therefore,
techniques such as immunohistochemistry (IHC) are
widely used to detect PrPSc as a marker of disease and
diagnose experimental [7] or naturally occurring [9,10]
TSEs.
Scrapie, the archetypal TSE which affects small rumi-
nants, is not considered to be a public health risk and is
known for centuries [11-13]. In contrast, bovine spongi-
form encephalopathy (BSE) is a TSE of cattle first recog-
nised in 1986 [14]. After its discovery, novel spongiform
encephalopathies in captive ruminants [15] and cats [16-
18] and a variant of Creutzfeldt-Jakob disease (vCJD) in
humans [19-21] were identified. Subsequently a link be-
tween BSE and these new emerging TSEs was estab-
lished and wild type mouse bioassay contributed in
determining this association [22].
Wild type mouse bioassay has been used to study the
infectivity of TSE sources and to identify different strainsntral Ltd. This is an Open Access article distributed under the terms of the
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ology, strains are identified after serial passage in a given
mouse line to allow a TSE agent to adapt into the new
host by overcoming the low attack rates, and prolonged
and variable incubation periods which are experienced
during primary isolation of the agent into mice, a prop-
erty called the species or transmission barrier. For strain
typing C57BL/6, RIII and VM are the most commonly
used wild type mouse lines either alone or in combin-
ation [26].
The amino acid sequence of PrP in RIII and C57BL/6
mice (Prnpa) differs from that of VM mice (Prnpb) at
codons 108 and 189 (Prnpa – leucine, threonine; Prnpb
– phenylalanine, valine) [27,28]. This difference in Prnp
genotype affects both bioassay parameters which are
traditionally used to study TSEs in mice: the incubation
period and the lesion profile – a semi-quantitative as-
sessment of vacuolation at specific neuroanatomical
areas [23,24,29]. However, there are some differences in
the data observed between RIII and C57BL/6 mice chal-
lenged with the same TSE source or strain attributed to
genetic factors other than the PrP genotype [30,31]. Also
in RIII mice, even upon primary isolation, BSE and BSE
derived TSEs behave reproducibly with consistent, albeit
prolonged compared to serial passage, incubation period
and exhibit a single characteristic lesion profile [22,32-
34]. In contrast to RIII mice, primary isolation of BSE in
C57BL/6 and VM mice does not yield informative data
according to traditional parameters. However, as for
classical scrapie, the agent can be fully characterised in
these mouse lines upon serial passage. Incubation period
and lesion profile data obtained from the serial passage
of BSE through C57BL/6 and VM mice indicate that
there are two stable mouse adapted strains of BSE: 301C
which is derived after serial passage through C57BL/6
mice and 301V which results after serial passage through
VM mice [35].
The association of vCJD with BSE [22,36,37], the suc-
cessful experimental transmission of BSE to sheep
[38,39] and the first report of BSE in a goat [40], raised
the need to be able to confidently distinguish between
BSE and scrapie, and applying traditional methods on
RIII bioassays is regarded as one of the most reliable
approaches to do so [22,32]. There are some limitations,
however, as it has been demonstrated by recent studies,
according to which scrapie-infected sheep can produce a
similar incubation period and lesion profile to BSE upon
primary isolation in RIII mice [34,41]. It was still pos-
sible, however, to confirm these cases as scrapie using
histopathology, Western blot and IHC although detailed
description of the PrPSc types in the mouse brain was
not attempted. Other studies also indicate that an as-
sessment of the distribution of PrPSc in the brain could
aid discrimination of TSE source [42,43]. These data,although limited, suggest that assessment of PrPSc distri-
bution could provide an alternative approach to lesion
profiling in distinguishing BSE from non-BSE related
TSEs upon primary passage and the potential to diag-
nose BSE based on individual mice rather than groups of
animals makes this method very powerful as a discrimin-
atory tool. This approach has recently been employed to
help confirm BSE in a goat in UK where incubation
period and lesion profile data on primary isolation were
unavailable [44].
IHC is used routinely as a diagnostic tool in the study
of TSEs in large animals. Furthermore, IHC has been
used to characterise TSE sources within sheep by the
identification of different PrPSc types and the spatial dis-
tribution of each type in the brain to give specific PrPSc
distribution patterns [10,45-47]. It has been proposed
that these patterns may be dependent on agent strain,
host genetic parameters (the most profound of the host
factors being its PrP sequence) or a combination of both
[47]. In contrast, there is limited data available regarding
the systematic observation of PrPSc patterns and their
neuroanatomical distribution upon primary isolation in
murine TSE studies. The majority of studies involve
mouse-adapted scrapie strains, such as 87V or ME7, and
a systematic recording of the different PrPSc types in the
murine brain was not attempted [48-50].
In the current study we systematically studied and
recorded in detail the distribution of PrPSc through-
out the brain of wild type mice challenged with BSE
from bovine and ovine sources during primary isola-
tion or after serial passages using IHC and PET blot.
We were able to identify source- and strain-specific
markers, in addition to mouse lineage-specific markers
which could enhance our ability to discriminate be-
tween TSE sources and help characterise strains on
primary isolation.Materials and methods
Inocula selection
In the current study we examined retrospectively, using
IHC, selected BSE inocula which had previously been
bioassayed into RIII mice and at least in C57BL/6 or
VM mice. These inocula included five bovine BSE pools
composed of either natural or experimental BSE cases,
one ovine BSE pool and a single ovine BSE source. All
sources had been characterised previously in RIII mice
and their biological properties at primary isolation were
consistent with BSE [33].
Murine brains from BSE inoculated mice that were
diagnosed TSE positive at primary isolation were used to
prepare inocula for serial passages. In addition 301C or
301V infected murine brain reference materials were
also used for serial passages.
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For primary isolation 5–10 week old mice were inoculated
intracerebrally (20 μl) and intraperitoneally (100 μL) with
brain homogenates (10% w/v in normal saline) from BSE
affected cattle or sheep; each inoculum was administered
to groups of 20 mice. For serial passages groups of 10 mice
were inoculated intracerebrally with 20 μL of homogenate
(1% w/v in normal saline) from BSE affected mice. All
homogenates were microbiologically screened and treated
with antibiotics if required. Only bacteriologically clear
homogenates were used for inoculations.
Intracerebral inoculations were performed under gen-
eral anaesthesia using a 25G hypodermic needle attached
to a 1 mL insulin syringe. A plastic sheath was inserted
along the needle allowing only the distal 5 mm of the
needle to be exposed to ensure that the inoculum was
deposited at similar depth in each animal and minimize
tissue injury. The point of entry was approximately
3 mm dorsally from a point lying halfway between the
eye and the base of the ear. Insertion into the CNS was
achieved by gently rotating the syringe along its axis at
right angle with respect to the skull surface.
Mice were housed in standard mouse cages and were
monitored for clinical signs of disease by experienced ani-
mal attendants. Mice were euthanized after exhibiting
clinical signs of TSE disease for two consecutive weeks
unless the clinical progression of the disease was so rapid
that they had to be euthanized sooner on welfare grounds.
All mice that did not show clinical signs of TSE were
allowed to live until they were euthanized on welfare
grounds caused by other conditions (intercurrent deaths).
All animal procedures were performed in compliance
with the Animal (Experimental Procedures) Act 1986
under license issued by the UK Home Office and were
approved by the Ethics Review Committee .PrP-immunohistochemical (IHC) and Paraffin Embedded
Tissue (PET) blot analysis
After euthanasia the brain of each mouse was removed
aseptically and sectioned parasagitally. Approximately
one third was stored at −80°C for bioassay or biochem-
ical studies and two thirds were immersed in buffered
formalin for 48–72 h at room temperature. At the end
of the fixation the samples were sectioned at 4 different
coronal levels at the level of medulla (including the cere-
bellum), midbrain, thalamus (including hippocampus
and overlying cortex) and frontal cortex (including basal
ganglia) as described elsewhere [33].
Each coronal segment was embedded in paraffin wax
and histological sections (3 μm thick) from each level
were mounted on positively charged slides and were
subjected to IHC using the rabbit polyclonal anti-PrP
antibody Rb486 [51].Sections (3 μm thick) of samples that were analysed
with IHC were also processed fro PET blot using the
mouse monoclonal antibody 2 G11 as described previ-
ously [52,53].
Results
To confirm that the selected inocula were characteristic
of BSE, the lesion profile data from RIII mice were ana-
lysed. The typical BSE associated lesion profile which is
characterised by peaks at grey matter areas G1 (dorsal
medulla nuclei), G3 (cortex of the superior colliculus)
and G7 (septal nuclei of the paraterminal body) was
observed in all selected cases [22,32,33]. The attack rate,
incubation period and Western blot data generated by
these inocula in RIII mice were also consistent with BSE
(data not shown) suggesting that the selected sources
demonstrated typical BSE behaviour.
Identification and terminology of PrPSc types
A number of PrPSc types were observed in BSE-infected
mice. Different PrPSc types were identified and the follow-
ing terminology was used throughout the current study to
describe the observed PrPSc types in BSE-infected mice.
Granular
Granular type appeared as small particulate PrPSc depos-
its with indistinct borders that appeared to diffuse in the
neuropil (Figure 1a).
Aggregates
Focal dense deposition of PrPSc in the neuropil which
varied in dimensions (Figure 1b-c).
Plaques
Plaques appeared as discrete, organised deposits of PrPSc
with a central core surrounded by radiating fibrils within
the neuropil (Figure 1d). They were not encountered very
often and therefore cannot be considered a consistent fea-
ture of the IHC phenotype in BSE infected wild type mice.
Strict criteria were applied for the characterisation of pla-
ques: non fibrillar formations that lacked a central core
were classified as aggregates even if they had a distinct cir-
cular or elliptical border and a relatively organised struc-
ture. Such structures may result from real plaques if the
sectioning plane is distant from the central core of the
plaque. Alternatively they may represent plaques at early
stages of their formation before they develop fully charac-
teristic plaque features. The appearance of plaques was
not consistent or unique to BSE and therefore their sig-
nificance as a discriminating parameter was limited.
Punctate
Punctate deposits appeared as discrete, small particles of
PrPSc within the neuropil (Figure 1e). Occasionally, this
Figure 1 PrPSc types identified in wild type mice infected with BSE. For definition of each type refer to the text. PrPSc types shown are
(a) granular, (b) small and medium aggregates, (c) medium and large aggregates, (d) fibrillar plaque, (e) intraglial (f) speckled, (g) intraneuronal,
(h and i) stellate, (j) intraglial, (k) larger intraglial deposits observed in the habenular nucleus of VM mice and (l) perineuronal. Scale bar represents
50 μm except in (i) where it represents 100 μm.
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appearance.Speckled
Speckled type appeared as clustered dense deposits, dis-
tinct from aggregates and plaques, and can be associated
with glial cells (Figure 1f ).Intraneuronal
Intraneuronal type appeared as multiple small, discrete
granules of PrPSc within the cytoplasm of larger neurons.
It was observed in targeted nuclei that usually house
large neurons, such as locus coeruleus, cerebellar and
red nuclei (Figure 1g). The appearance of this feature
was not consistent or unique to BSE and therefore its
significance as a discriminating parameter was limited.
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Stellate type appeared as small, numerous radiating
“star-like” deposits of PrPSc within the neuropil
(Figure 1h) and was easier to identify at lower magnifica-
tion (Figure 1i). The designation of this term was based
purely on morphological criteria although in ruminants
this term has been associated with glial cells.
Intraglial
Intraglial type appeared as dense deposits in close proxim-
ity to the nuclei of glial cells (Figure 1j). As with the stellate
type, this is also an operational term indicating the com-
mon features of these deposits with the intraglial deposits
observed in TSE affected ruminants. In VM mice an intra-
glial type comprising larger deposits was also observed
more consistently in the habenular bodies (Figure 1k).
Perineuronal
Perineuronal type appeared as deposition of PrPSc
around neuronal perikarya. (Figure 1l). As with the
intraneuronal type the significance of perineuronal type
as a unique BSE feature was restricted, and therefore the
significance of this PrPSc type as a BSE trait was limited.
In contrast to standard TSE lesion protocols where 9
grey matter and 3 white matter brain areas are analysed,
it was necessary and advantageous to examine all neu-
roantomical areas presented in each coronal section
when mapping PrPSc types. The consideration of specific
PrPSc types in exact neuroanatomical structures facili-
tated the construction of PrPSc distribution patterns.
PrPSc distribution patterns resulting from primary
isolation of BSE in C57BL/6 and RIII mice
Inoculation of BSE into C57BL/6 and RIII mice resulted
in very similar patterns which was expected as these two
mouse lines share the same PrP genotype. Therefore the
description of the PrPSc patterns is based on observa-
tions in C57BL/6 mice and any differences in the RIII
mice are indicated.
Medulla section
Granular deposits were detected throughout the medulla
with varying intensity; occasionally small to medium
aggregates were also dispersed throughout the medulla.
This pattern was observed with higher intensity in the
cochlear nuclei. Intraglial and intraneuronal types were
also observed but not consistently and their presence in
the medulla is not considered to be a strong discrimin-
atory characteristic of BSE in these mice. In the locus
coeruleus and the cochlear and cerebellar nuclei the in-
tensity of the immunolabelling was greater than in the
rest of the medulla. Similar observations were made in
the medullae of RIII mice although the immunolabelling
was less intense.The granular and the molecular layers of the cerebel-
lum in mice with BSE characteristically displayed wide-
spread granular deposits and aggregates ranging from
small to large. In RIII mice this pattern was less intense
and the molecular layer was rarely populated with PrPSc
deposits.
Midbrain section
Granular deposits were observed throughout the mid-
brain accompanied by small to medium aggregates and
low level intraglial labelling. The raphe and red nuclei
and, in RIII mice the pars compacta of the substantia
nigra, usually appeared more prominent, because this
pattern became denser, with the presence in the red nu-
clei of bigger aggregates and, in C57BL/6 mice of intra-
neuronal PrPSc. A distinctive characteristic of the RIII
mice was that the superior grey layer of the superior col-
liculus appeared spared of PrPSc deposition at low
magnification.
Thalamic and frontal sections
At the thalamic level the hypothalamus, especially the
dorsomedial nuclei, displayed granular type with small
aggregates distributed unevenly. Granular deposits were
also observed in the habenular bodies and in the para-
ventricular nucleus of the thalamus. In C57BL/6 mice
the zona incerta was usually easily distinguishable, due
to the presence of a granular deposits, small to medium
aggregates and sometimes perineuronal type. Wide-
spread granular type was observed in the CA2 and, to a
lesser extent, in the CA1 areas of the hippocampus, both
in C57BL/6 and RIII mice. In some mice small aggre-
gates located near the hippocampal fissure were also
observed. Occasionally, plaques would be observed
mainly along the corpus callosum and the external
capsule.
In the cerebral cortex granular deposits were distribu-
ted along the internal pyramidal layer (layer V) with
varying intensities spatially; in RIII mice this labelling
appeared less intense overall. In the dorsolateral septal
nuclei the granular deposits were milder and more
evenly distributed. Granular deposits were widespread in
the caudate putamen and in C57BL/6 mice this area also
hosted small PrPSc aggregates.
Characteristic aspects of this pattern which could help
identify BSE in a single Prnpa mouse using IHC or PET
blot are presented in Figure 2.
PrPSc distribution patterns resulting from primary
isolation of BSE in VM mice
Medulla section
Punctate deposits were distributed throughout the medulla
which was also affected by granular deposits of varying in-
tensity where small aggregates, intraglial and intraneuronal
Figure 2 Some distinctive features of BSE in C57/BL6 mice. (a)-(d) Immunohistochemistry showing characteristic features in CA2 area (a), red
nucleus (b), cerebellum (c) and the increased intensity of labelling in locus coeruleus and cochlear nucleus in the medulla (d). (e)–(h) The same
areas stained using the PET-blot approach. Both methods revealed similar distribution of PrPSc but IHC confered higher resolution.
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tense in the locus coeruleus and the cerebellar and coch-
lear nuclei, although in this last area no intraneuronal
deposition was observed. In addition, the locus coeruleus
was the only neuroanatomical area where it was possible to
observe the speckled PrPSc deposits, a distinctive feature of
the VM mice. The nucleus of the solitary tract appeared
relatively spared of granular type compared to the neigh-
bouring areas, displaying only punctate PrPSc deposition.
In the granular layer of the cerebellum punctate and
granular types were distributed unevenly with slightly
increased labelling in the white matter border. The white
matter of the cerebellum was also affected, mainly with
granular deposits. In the molecular layer granular depos-
its appeared infrequently.
Midbrain section
In the midbrain the peri-aqueductal grey matter characteris-
tically appeared spared of granular type compared to the
surrounding areas, displaying only a punctate PrPSc depos-
ition as was also observed in the midline raphe and the soli-
tary tract. The rest of the mid-brain presented granular
and intraglial deposits with varying intensity whilst
punctate deposits and small aggregates were observed
throughout the section. In the substantia nigra, the inter-
penducular and red nuclei the intensity of the staining was
increased compared to the rest of the midbrain.
Thalamic and frontal sections
At the thalamic level the habenular bodies, thalamus, lat-
eral thalamus, laterodorsal thalamic nuclei and zona
incerta displayed granular and punctate types thoroughout,
with small aggregates and intraglial type appearing multi-
focally. Intraglial deposits were particularly prominent inthe habenular bodies. On the contrary, the hypothalamus
and lateral hypothalamus were characterised by the pres-
ence of punctate deposition alone, which occasionally
aligned to form beaded linear PrPSc deposits. Occasionally
the arcuate thalamic nuclei and the median eminence dis-
played granular deposits and aggregates.
Punctate type was evident in the hippocampus and the
dentate gyrus. In addition stellate deposits could be
observed in the dentate gyrus, a characteristic which be-
came more prominent and extensive after serial passage.
Occasionally, plaques would be observed in the hippo-
campal molecular layer in the vicinity of the corpus cal-
losum and the external capsule.
In the internal pyramidal layer of the cerebral cortex
granular PrPSc deposition of variable intensity which
made it appear mottled was recorded. The same areas
were affected by intraglial deposits. Punctate deposition
was predominant in the vertical limb of the diagonal
band, medial preoptic band, ventral pallidum and dorso-
lateral septal nuclei. The dorsolateral septal nuclei were
also affected by weak granular deposits. On the contrary,
in the caudate putamen there were low levels of granular
and punctate deposits.
Characteristic features of this pattern which could help
identify BSE in a single Prnpb mouse using IHC or PET
blot are presented in Figure 3.
Primary isolation of ovine BSE demonstrated that the
distribution of PrPSc types in all mouse lines were indistin-
guishable from those observed for bovine BSE or for BSE
derived from other sources (data not shown). In addition
comparative studies with the anti-PrP antibody 2 G11
(data not shown) indicated that the PrPSc distribution pat-
terns detected were indistinguishable from that observed
with Rb486 suggesting that the patterns identified were
Figure 3 Some distinctive features of BSE in VM mice. (a)-(d) Immunohistochemistry showing characteristic features in the dentate gyrus
(a), periaqueductal grey mater (b), solitary tract (c) locus ceruleus (d). (e)–(h) The same areas stained using the PET blot approach. Both methods
revealed similar distribution of PrPSc but IHC confered higher resolution.
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PrPSc distribution patterns resulting from BSE serial
passages in C57BL/6 and VM mice
Between first and second passage of BSE in C57BL/6 mice
only subtle differences were introduced. They included a
wider distribution of granular deposits and small aggre-
gates in the hippocampus along the hippocampal fissure
and occasionally in other layers whilst in mice challenged
with ovine or bovine BSE the PrPSc appeared to be more
restricted in the hippocampal fissure and the CA2 area of
the hippocampus. In the cerebral cortex, in the proximity
of the cingulum, a partial double layer of granular PrPSc
was observed which appeared to overlay mainly alongFigure 4 Locus coeruleus of VM mice challenged with BSE. (a) Primary
PrPSc deposits are evident only on primary passage.cortical layer V and partially along the multiform layer
(layer VI) in its vicinity with the white matter - a distin-
guishing feature from primary isolation of BSE where
PrPSc was more restricted giving the appearance of a sin-
gle layer of granular deposits overlaying mainly cortical
layer V. The remaining characteristic features of BSE were
maintained after serial passage. The pattern observed at
the second passage remained unchanged after subsequent
serial passages of BSE isolates and was indistinguishable
from the pattern produced by reference strain 301C.
The most significant feature between first and second
passage of BSE in VM mice was a lack of appreciable
punctate PrPSc deposits. Also the speckled deposits in the
locus coeruleus were present only on primary isolation
(Figure 4). Stellate PrPSc deposits became more definedisolation; (b) second passage. The characteristic speckled
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observed in the hippocampus, the cerebral cortex along
layer V and the layers underlying the meninges and the
subiculum. In many of these areas during primary passage
the main PrPSc type was granular with uneven intensity
suggesting a pattern evolution. Other characteristic fea-
tures of serially passaged BSE were reminiscent of primary
isolation including a significant decrease of labelling in the
nucleus of the solitary tract, raphe nuclei and peri-
aqueductal grey matter, with evident PrPSc in surrounding
areas. As in the C57BL/6 mice this pattern also remained
unchanged after repeated serial passages of BSE isolates in
VM mice and was indistinguishable from the pattern gen-
erated by reference 301V.
Discussion
In this study we showed that after first passage of BSE in
C57BL/6, RIII or VM mice a number of PrPSc specific
deposits can be identified and their distribution in the
murine brains can generate high resolution patterns.
These distribution patterns were consistent and identifi-
able in individual mice. Although we only report here on
BSE generated patterns we are aware that these patterns
differ from the patterns produced in these mouse lines by
natural cases of classical scrapie [34,41,53,54]. Therefore
IHC can be used to identify TSE agents isolated in murine
bioassays and facilitate resolve ambiguous TSE cases. In-
deed this approach has been used successfully in two re-
cent reports to help reject the presence of BSE in two
sheep in one and confirm it in a goat in another [41,44].
Stabilization of a TSE agent in a wild type murine host
requires serial passages within this host which have a
significant effect on incubation period and lesion profiles
[26,41]. However, PrPSc patterns are affected little and in
a predictable way by serial passages [41,55,56]. This bio-
logical property makes PrPSc deposition pattern mapping
a powerful tool in the identification and definition of
TSE strains on first passage [34,41,44,54]. It can be ap-
plied to individual mice and therefore it is better suited
to identify strain diversity within single inocula in case
of co-infections [41,56]. It can also help substantially
with the characterisation of cases in which insufficient
mice succumb to disease for robust lesion profiles to be
constructed [44].The detailed description presented in
this study will hopefully provide a reference document
for identifying BSE in wild type mice. In addition it pro-
vides a methodological approach which can be applied
in other experimental rodents either wild type or trans-
genic to help identify TSE strains on primary isolation.
It is important to realise that it is not a requirement
that all strain specific markers or the entire pattern are
present in an individual mouse, although the majority
will be. However, conclusions should not be based on
single individual markers as some can be associated withother strains. For example, although in C57BL/6 mice
the granular deposits in the CA2 area of the hippocam-
pus are considered to be a BSE feature they can also be
induced by 221C, a murine classical scrapie strain.
Nevertheless, distinct differences in other markers can
make distinction between these two strains feasible [53].
Therefore, in order to conclude that a pattern in an indi-
vidual mouse signifies BSE or any other TSE strain it is
important that more than one individual IHC markers
which are compatible with a pattern produced by a spe-
cific TSE strain are identified; usually 3 preferably 4
characteristic IHC markers are adequate for strain iden-
tification in an individual mouse. The presence of a sin-
gle pattern with the addition of uncharacteristic markers
reminiscent of other strains or of elements of two pat-
terns may signify coinfection of two strains as previously
suggested [41,56].
Our observations are in agreement with the findings
of a previous report [43] especially with regard to the
distribution of PrPSc in the cerebellum and hippocam-
pus. However, our study is more detailed in terms of the
different PrPSc types and their distribution to specific
neuroanatomical locations. Although IHC has also been
applied to describe PrPSc patterns in murine adapted
TSE strains [49,50,57,58] the potential of this technique
as a powerful phenotypic tool that can be used to dis-
criminate TSE strains not only after adaptation in the
murine host but even at primary isolation has not been
realised until recently [34,41,44,54,59,60]. This is intri-
guing because PET- or Histo- blots have been used to
characterise successfully TSE strains during primary iso-
lation although they have lower resolution compared to
IHC as they only portray general PrPSc distribution
[42,61]; at this level of resolution IHC and PET- or
Histo-blots can be directly comparable and have been
used to show strain similarities [60].
In conclusion the current study utilised IHC to suc-
cessfully identify PrPSc patterns for BSE and BSE-derived
strains in wild type mice. In a similar study we have
identified PrPSc patterns in wild type mice that are asso-
ciated with classical scrapie strains [52]. There is no re-
semblance between any of the classical scrapie and BSE
patterns identified suggesting that PrPSc patterns in the
brain of wild type are strain specific and can be applied
even at primary isolation to provide a powerful tool to
aid TSE strain discrimination in individual animals in as-
sociation with other phenotypic parameters such as
Western blot.
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